| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The overall sentiment for JOHNSON & JOHNSON is neutral (overall -0.1, positive 1.9, negative -2) on 20251014. The forces of Market Risk Appetite (-1.6), Valuation Sentiment (-1.5), Sector Price Trend (-0.7), and Price Level Sentiment (-0.5) will drive down the price. The forces of Stock Price Trend (0.4), Option Sentiment (1.5), and Sentiment towards Fundamentals (1.9) will drive up the price. 'Long' is the preferred trading strategy. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Market Sentiment | Trend Sentiment | Action | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-14 | 1% | 0.1% | 190.8 | 80 | -0.03% | 0.27% | -0.1 | 0.4 | Short | 1.9 | 4.8 |
| 2025-10-13 | 0% | 0% | 190.86 | 83 | 0.08% | 0.53% | -0.8 | 1.2 | Short | -0.4 | -1.5 |
| 2025-10-12 | 0% | 0% | 1 | 1.1 | Long | -0.3 | -1.5 | ||||
| 2025-10-11 | 0% | 0% | 0.7 | 1.1 | Range | -0.8 | -1.5 | ||||
| 2025-10-10 | 0% | 0% | 190.71 | 86 | -0.19% | 0.59% | 1.1 | 1.1 | Long | -0.1 | 4.5 |
| 2025-10-09 | 0% | 0% | 191.07 | 92 | 0.71% | 0.7% | 1.4 | 1.4 | Range | 0.3 | -1.5 |
| 2025-10-08 | 0% | 0% | 189.72 | 92 | 0.44% | 0.71% | 1.7 | 1.3 | Range | 0.2 | 6.5 |
| 2025-10-07 | 0% | 0% | 188.88 | 94 | 0.37% | 0.66% | 1.5 | 1.3 | Range | 0.2 | -9.5 |
| 2025-10-06 | 0% | 0% | 188.18 | 97 | -0.24% | 0.77% | 3.1 | 1.5 | Range | 2.5 | -1.5 |
| 2025-10-05 | 0% | 0% | 3.6 | 1.9 | Range | 3.2 | -1.5 | ||||
| Both emotion scores and sentiment scores are calculated in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| 1 (2) J&J stock falls on earnings: Why this analyst is still bullish Johnson & Johnson (JNJ) stock is in focus after the company reported earnings and announced a spin-off of its orthopedics business. Guggenheim Securities senior research analyst and managing director Vamil Divan joins Market Catalysts to examine the earnings print, discuss what's driving the stock lower, and outline his bullish case for the stock. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts. (https://finance.yahoo.com/) Tue. Oct 14, 2025 | |
| 2 (6) J&J to spin off orthopedics business, sees 2026 sales growth of over 5% J&J to spin off orthopedics business, sees 2026 sales growth of over 5% (https://www.investing.com/) Tue. Oct 14, 2025 | |
| 3 (5) Johnson & Johnson outlook, Oracle & AMD team up, GM's EV charge Morning Brief host Julie Hyman outlines three of Wall Street's top stories on Tuesday: Johnson & Johnson (JNJ) earnings, the Oracle (ORCL) and AMD (AMD) chip deal, and General Motors' (GM) electric vehicle (EV) charge. To watch more expert insights and analysis on the latest market action, check out more Morning Brief. (https://finance.yahoo.com/) Tue. Oct 14, 2025 | |
| 4 (7) J&J to spin off orthopedics business, sees 2026 sales growth of over 5% (Reuters) -Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years as it sharpens focus on higher-growth healthcare segments. J&J; also outlined expectations for faster growth into 2026, driven by new drug launches and a strengthened medical devices portfolio, and raised its 2025 sales forecast after reporting quarterly earnings that topped Wall St (https://finance.yahoo.com/) Tue. Oct 14, 2025 | |
| 5 (8) Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff Johnson & Johnson’s stock rose toward a record after a beat-and-raise earnings report and announcement of plans to separate its orthopedics business. (https://www.marketwatch.com/) Tue. Oct 14, 2025 | |
| 6 (8) Johnson & Johnson To Separate Orthopedics Business, Boosts Annual Sales Outlook Johnson & Johnson beats Q3 estimates, raises 2025 sales guidance, and announces plans to spin off its $9.2 billion orthopedics business, DePuy Synthes. (https://www.benzinga.com/) Tue. Oct 14, 2025 | |
| 7 (8) Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff Johnson & Johnson’s stock rose toward a record after a beat-and-raise earnings report and announcement of plans to separate its orthopedics business. (https://www.marketwatch.com/) Tue. Oct 14, 2025 | |